Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Background

Dr. Meghana Gupta is a Law Clerk in the Boston office of Fish & Richardson. Her practice focuses on patent prosecution and counseling in life sciences, and also provides assistance with due diligence, freedom-to-operate, patent portfolio management, and landscape review. Dr. Gupta’s experience includes, life sciences, pharmaceutical, biotechnology, chemical and mechanical fields, having drafted and prosecuted patent applications in the fields of: regenerative medicine; biologics; medical devices; gene therapeutics; molecular diagnostics; nucleotide and nucleic acid analogs; microbiology; cell biology; industrial processes and bioprocesses; pharmaceutical agents, treatments and delivery; metabolic engineering; polymer and organic chemistry; plant and agriculture sciences; micro- and nano-electromechanical systems, foods, and nutraceuticals. She has experience with both U.S. and International patent practice.

Dr. Gupta’s graduate work included understanding and elucidating the role of tyrosine phosphorylation of small guanine nucleotide exchange factors in various cell signaling pathways implicated in cancers.

Education

University of Pittsburgh School of Law 2019
J.D.


Cape Western Reserve University 2014
Molecular Pharmacology, Ph.D.


Rutgers University 2007
Genetics and Microbiology and Evolutionary Anthropology, Bachelors
Dean's List, Honors in Genetics

Other Distinctions

Certifications

Registered Patent Agent, U.S. Patent and Trademark Office; March 2015

Publications

Gupta M., Qi X., Thakur V., and Manor D. “Tyrosine phosphorylation of Dbl regulates GTPase signaling.” Journal of Biological Chemistry (2014)

Gupta M., Kamynina E., Morley S., Chung S., Muakkassa N., Wang H., Brathwaite S., Sharma G., and Manor D. ” Plekhg4 is a novel Dbl-family guanine nucleotide exchange factor for Rho-family GTPases.” Journal of Biological Chemistry (2013)

Calvert RJ, Gupta M., Maciag A., Shiao YH., and Anderson LM. “K-ras 4A and 4B mRNA levels correlate with superoxide in lung adenocarcinoma cells, while at the protein level, only mutant K-ras 4A protein correlates with superoxide.” Lung Cancer (2013)

 

Services

Industries